Delivery Order SPE2DB22D2206-SPE2DB24FDR58
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, primarily the diabetes medication Ozempic, to the Defense Logistics Agency (DLA). The award, valued at $9,402.03, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the supply of Ozempic, a medication used in the treatment of diabetes. The delivery order, valued at $6,302.82, has a firm fixed price and an ultimate completion date of April 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical and medical supplies, including Trulicity, Ozempic, Mounjaro, and other prescription drugs, to support the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $24,536.32, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the Defense Logistics Agency (DLA) Troop...
- This federal contract award, valued at $2,854.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,813.63 for the supply of Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 2, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of various pharmaceutical products, including Trulicity, Ozempic, Mounjaro, and other prescription drugs. The contract is valued at $71,678.00 and has a period of performance through December 13, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00. The contract, which runs through November 2026, provides a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,151.12 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,415.77 firm fixed price delivery order is for the pharmaceutical product Ozempic, a medication used to manage diabetes. The contract has an ultimate completion date of October 12, 2023 and was awarded on October 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,049.22, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3ml, a specialty medication. This award is part of Amerisourcebergen's larger $999,999,999 IDC with the DLA, which serves as a primary vehicle for the company to provide a comprehensive range of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FDR58Delivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a variety of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,278.58 with a period of performance through October 12, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other supplies, to support military and veterans' healthcare programs globally. This particular delivery order is for the diabetes medication Ozempic. The contract was awarded through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/11/23 |